Vivus Inc Institutional Investor Sentiment Worsened in 2017 Q4

April 17, 2018 - By Maria Brooks

Sentiment for Vivus Inc (NASDAQ:VVUS)

Vivus Inc (NASDAQ:VVUS) institutional sentiment increased to 0.57 in Q4 2017. Its up 0.04, from 0.53 in 2017Q3. The ratio has improved, as 17 institutional investors increased or started new holdings, while 30 sold and reduced their holdings in Vivus Inc. The institutional investors in our partner’s database now have: 25.91 million shares, down from 32.65 million shares in 2017Q3. Also, the number of institutional investors holding Vivus Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 9 Reduced: 21 Increased: 9 New Position: 8.

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company has market cap of $43.47 million. The firm offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 or greater, or 27 or greater in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol; and STENDRA, an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. It currently has negative earnings. It is also developing Qsymia, which has completed Phase II studies for the treatment of obstructive sleep apnea and diabetes, as well as for other obesity-related diseases, including nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, hyperlipidemia, and hypertension.

The stock decreased 1.68% or $0.01 during the last trading session, reaching $0.41. About 232,075 shares traded. VIVUS, Inc. (NASDAQ:VVUS) has declined 65.45% since April 17, 2017 and is downtrending. It has underperformed by 77.00% the S&P500.

Menta Capital Llc holds 0.02% of its portfolio in VIVUS, Inc. for 156,421 shares. Acadian Asset Management Llc owns 2.68 million shares or 0.01% of their US portfolio. Moreover, Jacobs Levy Equity Management Inc has 0.01% invested in the company for 754,600 shares. The Texas-based Next Financial Group Inc has invested 0.01% in the stock. Ajo Lp, a Pennsylvania-based fund reported 1.57 million shares.#img1#

VIVUS, Inc. (NASDAQ:VVUS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: